Vanda Pharmaceuticals
VNDA
VNDA
147 hedge funds and large institutions have $224M invested in Vanda Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 50 increasing their positions, 51 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
2% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 51
54% less call options, than puts
Call options by funds: $812K | Put options by funds: $1.75M
Holders
147
Holding in Top 10
–
Calls
$812K
Puts
$1.75M
Top Buyers
| 1 | +$2.81M | |
| 2 | +$2.66M | |
| 3 | +$2.48M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$894K |
| 5 |
KAM
Krensavage Asset Management
New York
|
+$776K |
Top Sellers
| 1 | -$4.26M | |
| 2 | -$2.58M | |
| 3 | -$1.5M | |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
-$1.45M |
| 5 |
Morgan Stanley
New York
|
-$1.31M |
